India to Russia: Guaifenesin Export Trade Route
India has recorded 34 verified shipments of Guaifenesin exported to Russia, representing a combined trade value of $841.3K USD. This corridor is served by 3 active Indian exporters, with an average shipment value of $24.7K USD. The leading Indian exporter is AGIO PHARMACEUTICALS LIMITED, which accounts for 75% of total export value with 27 shipments worth $631.0K USD. On the buying side, AGIO RUS LLC is the largest importer in Russia with $713.6K USD in purchases. The top 3 suppliers — AGIO PHARMACEUTICALS LIMITED, AGIO PHARMACEUTICALS LIMITED , AGIO PHARMACEUTICALS LTD — together control 100% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Russia Guaifenesin corridor is one of India's established pharmaceutical export routes, with 34 shipments documented worth a combined $841.3K USD. The route is dominated by AGIO PHARMACEUTICALS LIMITED, which alone accounts for roughly 75% of all export value, reflecting the consolidated nature of India's guaifenesin manufacturing sector.
Across 3 active suppliers, the average shipment value stands at $24.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (67%) and air (17%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during July–September, with an average transit time of 15 days port-to-port. The route has recorded an annual growth rate of 30.5%, placing it at rank #10 among India's top guaifenesin export destinations globally.
On the import side, key buyers of Indian guaifenesin in Russia include AGIO RUS LLC, AGIO RUS LLC , OOO E T C PHARMA. AGIO RUS LLC is the single largest importer with 28 shipments valued at $713.6K USD.
Route Characteristics
- Average transit15 days
- Peak seasonQ3
- Primary modeMulti-modal
- Top portJNPT/ NHAVA SHEVA SEA
Market Position
- Global rank#10
- Annual growth+30.5%
- Demand growth+27.3%
- Regulatory ease68/100
Top 10 Indian Guaifenesin Exporters to Russia
Showing top 10 of 3 Indian suppliers exporting Guaifenesin to Russia, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | AGIO PHARMACEUTICALS LIMITED Avg $23.4K per shipment | 27 | $631.0K | 75.0% |
| 2 | AGIO PHARMACEUTICALS LIMITED Avg $24.8K per shipment | 5 | $123.8K | 14.7% |
| 3 | AGIO PHARMACEUTICALS LTD Avg $43.3K per shipment | 2 | $86.5K | 10.3% |
This table shows the top 10 of 3 Indian companies exporting guaifenesin to Russia, ranked by total trade value. The listed exporters are: AGIO PHARMACEUTICALS LIMITED, AGIO PHARMACEUTICALS LIMITED , AGIO PHARMACEUTICALS LTD. AGIO PHARMACEUTICALS LIMITED is the dominant supplier with 27 shipments worth $631.0K USD, giving it a 75% market share.
Top 10 Guaifenesin Importers in Russia
Showing top 10 of 3 known buyers in Russia receiving Guaifenesin shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian guaifenesin in Russia include AGIO RUS LLC, AGIO RUS LLC , OOO E T C PHARMA. The largest importer is AGIO RUS LLC, accounting for $713.6K USD across 28 shipments — representing 85% of all guaifenesin imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | AGIO RUS LLC | 28 | $713.6K | 84.8% |
| 2 | AGIO RUS LLC | 5 | $123.8K | 14.7% |
| 3 | OOO E T C PHARMA | 1 | $3.9K | 0.5% |
Top 10 Guaifenesin Formulations Imported by Russia
Showing top 10 of 6 product formulations shipped on the India to Russia Guaifenesin route, ranked by trade value
Russia imports a wide range of guaifenesin formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — KOFASMA SYRUP 200 ML (BROMHEXINE + GUAIFENESIN + SALBUTAMOL SYRUP) — accounts for $546.4K USD across 23 shipments. A total of 6 product variants have been identified in the shipment records.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | KOFASMA SYRUP 200 ML (BROMHEXINE + GUAIFENESIN + SALBUTAMOL SYRUP) | 23 | $546.4K | 64.9% |
| 2 | KOFASMA SYRUP 200 ML BROMHEXINE + GUAIFENESIN + SALBUTAMOL SYRUP | 4 | $148.4K | 17.6% |
| 3 | KOFASMA SYRUP 100 ML (BROMHEXINE + GUAIFENESIN + SALBUTAMOL SYRUP) | 4 | $59.6K | 7.1% |
| 4 | KOFASMA SYRUP 100 ML SALBUTAMOL + BROMOHEXINE + GUAIFENESIN SYRUP | 1 | $48.7K | 5.8% |
| 5 | KOFASMA SYRUP 100 ML (SALBUTAMOL + BROMOHEXINE + GUAIFENESIN SYRUP) | 1 | $34.3K | 4.1% |
| 6 | KOFASMA SYRUP 200 ML SALBUTAMOL BROMOHEXINE GUAIFENESIN SYRUP SALBUTAMOL SULPHATE EQ TO SALBUTAMOL BP 2 0MG | 1 | $3.9K | 0.5% |
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Balanced freight mix — 67% sea for bulk, 17% air for urgent orders.
Top Ports of Origin
JNPT/ NHAVA SHEVA SEA handles the highest volume with 12 shipments. Transit time averages 15 days by sea.
Market Dynamics
India's guaifenesin exports to Russia are driven primarily by a handful of large-scale manufacturers. AGIO PHARMACEUTICALS LIMITED with 27 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 3 active exporters signals a competitive but concentrated market — buyers in Russia benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — AGIO PHARMACEUTICALS LIMITED, AGIO PHARMACEUTICALS LIMITED , AGIO PHARMACEUTICALS LTD — together account for 100% of total trade value on this route. The average shipment value of $24.7K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as kofasma syrup 200 ml bromhexine + guaifenesin + salbutamol syrup and kofasma syrup 100 ml (bromhexine + guaifenesin + salbutamol syrup), suggesting that buyers in Russia tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, AGIO RUS LLC is the largest importer with 28 shipments worth $713.6K USD — representing 85% of all guaifenesin imports from India on this route.
Route Statistics
- Trade Volume
- $841.3K
- Avg. Shipment
- $24.7K
- Suppliers
- 3
- Buyers
- 3
- Transit (Sea)
- ~15 days
- Annual Growth
- +30.5%
Related Analysis
Other Guaifenesin Routes
Unlock the Full India to Russia Guaifenesin Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 34 shipments on this route.
Frequently Asked Questions — India to Russia Guaifenesin Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Guaifenesin to Russia?
The leading Indian exporters of Guaifenesin to Russia are AGIO PHARMACEUTICALS LIMITED, AGIO PHARMACEUTICALS LIMITED , AGIO PHARMACEUTICALS LTD. AGIO PHARMACEUTICALS LIMITED holds the largest market share at approximately 75% of total trade value on this route.
Q What is the total value of Guaifenesin exports from India to Russia?
India exports Guaifenesin to Russia worth approximately $841.3K USD across 34 recorded shipments. The average value per shipment is $24.7K USD.
Q Which ports does India use to ship Guaifenesin to Russia?
The most active port of origin is JNPT/ NHAVA SHEVA SEA with 12 shipments. Indian exporters primarily use a mix of sea and air freight for this route, with 67% of shipments going by sea and 17% by air.
Q How long does shipping take from India to Russia for Guaifenesin?
The average transit time for Guaifenesin shipments from India to Russia is approximately 15 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during July–September.
Q Is the India to Russia Guaifenesin trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 30.5% with demand growth tracking at 27.3%. The route is ranked #10 among India's top Guaifenesin export destinations globally.
Q How many suppliers are active on the India to Russia Guaifenesin route?
There are currently 3 active Indian suppliers exporting Guaifenesin to Russia. The market is moderately concentrated with AGIO PHARMACEUTICALS LIMITED accounting for 75% of total shipment value.
Q Who are the main importers of Guaifenesin from India in Russia?
The leading importers of Indian Guaifenesin in Russia include AGIO RUS LLC, AGIO RUS LLC , OOO E T C PHARMA. AGIO RUS LLC is the largest buyer with 28 shipments worth $713.6K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Russia export trade corridor identified from Indian Customs (DGFT) records for Guaifenesin.
- 2.Supplier/Buyer Matching: 3 Indian exporters and 3 importers in Russia matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 34 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
34 Verified Shipments
3 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists